ReviewEMBO reports2026
Viral subversion of B-cell tolerance: mechanisms linking infection to autoimmunity.
Review in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Viral infections are increasingly recognized as triggers of autoimmunity, yet the mechanisms linking viral infection to breakdown of B-cell tolerance remain incompletely understood. B-cell tolerance is maintained through sequential central and peripheral checkpoints that normally eliminate or silence self-reactive clones. Viral infections converge on shared mechanisms, including inflammatory cytokines, innate immune activation, molecular mimicry, and persistent antigen exposure, while also promoting polyreactivity, thereby enhancing the survival, activation, and expansion of autoreactive B cells. In this review, we propose that autoimmune outcomes are determined less by viral identity than by the immunological and anatomical context in which tolerance fails. We integrate mechanistic and clinical evidence across systemic, localized, and neurotropic viral infections to present a unifying framework for virus-induced B-cell tolerance breakdown. This framework identifies conserved principles underlying post-viral autoimmunity and provides a foundation for developing therapeutic strategies to preserve B-cell tolerance.
Identifiers
42859222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.